Acasti Pharma | ACST - Cost Of Sales

Stock Price
3.60
Daily Change
0.12 3.45%
Monthly
-3.49%
Yearly
11.11%
Q1 Forecast
3.54

Acasti Pharma reported $0 in Cost of Sales for its fiscal quarter ending in March of 2022.





Cost Of Sales Change Date
Addus HomeCare USD 249.99M 10.51M Sep/2025
Amarin USD 16.89M 18.51M Mar/2025
Cassava Sciences USD 3.96M 1.16M Sep/2025
Knight Therapeutics CAD 47.25M 990K Sep/2024
Option Care Health USD 1.18B 31.36M Sep/2025
Organigram Holdings CAD 77.46M 14.63M Sep/2025
Tilray USD 164.37M 8.41M Sep/2025